1.Clinical research on treatment of advanced primary liver cancer with combination of thymosinα1 and arsenic trioxide
Journal of Clinical Hepatology 2015;31(4):564-568
Objective To evaluate the efficacy of thymosin ɑ1 combined with arsenic trioxide in the treatment of advanced primary liver cancer (PLC).Methods A total of 59 patients with advanced PLC who were admitted to Jiangyan Hospital of Traditional Chinese Medicine from July 201 1 to July 2014 were divided into two groups:control group and combination therapy group.The two groups were given symptom-atic and supportive treatment to protect the liver.In addition,29 cases in the control group were treated with arsenic trioxide,while 30 cases in the combination therapy group were administrated with thymosin ɑ1 combined with arsenic trioxide.Comparison of continuous data be-tween the two groups was made by independent-samples t test,and comparison of categorical data was made by chi-square test.Results There was a significant difference in clinical benefit rate between the control group and the combination therapy group (37.9% vs 66.7%,χ2 =4.88,P<0.05).The combination therapy group had significantly higher improvement rate of the quality of life (63.3%vs 37.9%,χ2 =3.81,P<0.05)and the pain remission rate (76.7%vs 44.8%,χ2 =6.28,P<0.05)than the control group.The levels of alpha fetal protein,carcinoembryonic antigen,carbohydrate antigen 199,and gamma glutamyl transpeptidase decreased in both groups,and the combination therapy group had significantly higher decreases in these indices than the control group (P<0.05).The combination thera-py group had significantly increased percentages of CD3 +and CD4 +T cells and CD4 +/CD8 +ratio (P<0.05)and a significantly reduced percentage of CD8 +T cells (P<0.01)after treatment.However,there was no significant difference in toxic or side effects between the two groups.Conclusion For patients with advanced PLC,the combination of thymosin ɑ1 and arsenic trioxide can improve the quality of life and the immune function of patients,and no obvious toxic or side effects are found.So it holds promise for clinical application.
2.Setup error of Orfit versus vacuum bag in radiotherapy for cervical cancer
Lijuan GAO ; Jiamin HUANG ; Jun HUANG ; Jianxin SU ; Yuqi WU ; Chengguang LIN
Chinese Journal of Radiation Oncology 2017;26(9):1080-1083
Objective To compare the setup errors of the negative pressure vacuum air cushion (vacuum bag) and the Orfit body foam fixator (Orfit frame) in radiotherapy for cervical cancer.Methods A total of 40 patients receiving three-dimensional radiotherapy for cervical cancer were enrolled in this study and equally and randomly divided into vacuum bag group and Orfit frame group.And the two groups were divided into Orfit-1 group, Orfit-2 group, vacuum-1 group, and vacuum-2 group according to the treatment course.The Orfit-1 group and vacuum-1 group were the data in the first 12 treatments, while the Orfit-2 group and vacuum-2 group were the data in the following 13 treatments.A cone-beam computed tomography scan was performed before each treatment to analyze setup error and then the body position was corrected to start the treatment.Comparison of continuous data between groups was made by paired t-test, while comparison of categorical data was made by chi-square test.Results There was a significant difference in the setup error in y-axis direction between the Orfit-1 group and the Orfit-2 group (P=0.003) and the setup error in r-axis direction between the vacuum-1 group and the vacuum-2 group (P=0.013).There were no significant differences in the setup errors in four directions (x-axis, y-axis, z-axis, and r-axis) between the Orfit-1 group and the vacuum-1 group (P>0.05).There were significant differences in the setup errors in y-axis and z-axis directions between the Orfit-2 group and the vacuum-2 group (P=0.007;P=0.001).Conclusions The Orfit frame and the vacuum bag have their own advantages and disadvantages in the fixation of body position in radiotherapy for cervical cancer.The setup error can be improved by long vacuum bags, ultrasound bladder capacity scanner, image-guided radiotherapy, or sectional radiotherapy plan.
3.Clinical effect of 7.5 mm QWIX screw fixation of femoral neck fracture
Ming QIN ; Shichang GAO ; Hua ZHOU ; Yuan CHENG ; Jie LIU ; Chengguang WANG
Chinese Journal of Trauma 2015;31(10):925-930
Objective To evaluate the clinical effect of femoral neck fracture fixed with 7.5mm QWIX screws and to find out risk factors for avascular necrosis of the femoral head postoperatively.Methods From January 2009 and March 2013, 53 patients underwent closed or open reduction of femoral neck fracture with 7.5mm QWIX screws.Healing process of fracture, complications of internal fixation, Harris hip score and avascular necrosis of the femoral head were followed up.The data reviewed were age, gender, injury patterns, fracture type, preoperative waiting time, reduction ways, reduction condition, and others.Unilateral and multivariate Logistic analysis were applied to identify factors for avascular necrosis of the femoral head.Results All patients were followed up for 2-5 years (mean, 3.4 years).There was no non-union at follow-up, and all the screws were in the original site without loosening, cut-out or penetration.Mean Harris score was 91.2 points (range, 68 to 100 points) 2 years after operation, including 42 excellent, 6 good, 1 fair and 4 poor results with the excellent-good rate of 91%.Four patients (8%) had avascular necrosis 12 to 15 months after operation.With Logistic regression analysis, fracture anatomic type was identified as the only factor for avascular necrosis of the femoral head.Conclusions The 7.5 mm QWIX fixation screw provides rigid fixation, high healing rate and low incidence of avascular necrosis of the femoral head, appearing to be a good hardware to repair femoral neck fracture.Avascular necrosis of the femoral head is associated with the anatomic type of femoral neck fracture after operation.
4.Development and application of MOSAIQ integration platform based on radiotherapy workflow
Xin YANG ; Zhenyu HE ; Xiaobo JIANG ; Maosheng LIN ; Ningshan ZHONG ; Jiang HU ; Zhenyu QI ; Yong BAO ; Qiaoqiao LI ; Baoyue LI ; Lianying HU ; Chengguang LIN ; Yuanhong GAO ; Hui LIU ; Xiaoyan HUANG ; Xiaowu DENG ; Yunfei XIA ; Mengzhong LIU ; Ying SUN
Chinese Journal of Radiation Oncology 2017;26(8):918-923
Objective To develop a MOSAIQ Integration PlatformCHN (MIP) based on the workflow of radiotherapy (RT) and to meet the actual requirements in China and the special needs for the radiotherapy department.Methods MIP used C/S (client-server) structure mode running on the local network in the hospital and its database was based on the Treatment Planning System (TPS) and MOSAIQ database.Five network servers,as the core hardware,supplied data storage and network service based on cloud services.The core software was developed based on Microsoft Visual Studio Platform using C# network programming language.The MIP server could simultaneously offer network service for about 200 workstations,including entry,query,statistics,and print of data.Results MIP had 15 core function modules,such as Notice,Appointment,Billing,Document Management (application/execution),and System Management,which almost covered the whole workflow of radiotherapy.Up to June 2016,the recorded data in the MIP were as follows:13546 patients,13533 plan application forms,15475 RT records,14656 RT summaries,567048 billing records,and 506612 workload records.Conclusions The MIP based on the RT workflow has been successfully developed and used in clinical practice.It is an important part of radiotherapy information system construction with the advantages of intuitive operation,real-time performance,data security,and stable operation.It is digital,paperless,user-friendly,and convenient for the retrieval and statistics of data as well as information sharing and department management,and can significantly improve the efficiency of the department.More functions can be added or modified to enhance its potentials in research and clinical practice.